Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H11N3O2 |
Molecular Weight | 169.1811 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=NC=C(N1C)[N+]([O-])=O
InChI
InChIKey=NTAFJUSDNOSFFY-UHFFFAOYSA-N
InChI=1S/C7H11N3O2/c1-5(2)7-8-4-6(9(7)3)10(11)12/h4-5H,1-3H3
Originator
Sources: http://www.google.ru/patents/US3961068 | https://getd.libs.uga.edu/pdfs/hu_jinghui_200212_phd.pdf
Curator's Comment: # Hoffmann-La Roche Inc.
Approval Year
Sample Use Guides
Ipronidazole is administered through the feed at levels of approximately 0.006253% (prevention) to 0.025% (treatment). Continuous feeding of ipronidazole at a concentration of 100 g/ton in feed has been shown to prevent swine dysentery. Administration of ipronidazole at 200 to 800 mg/gal of drinking water for 7 days was effective in treating swine dysentery.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7181959
2.3 uM/mg protein of Ipronidazole induced a 60% decrease in rabbit heart mitochondrial ADP-stimulated oxygen uptake using glutamate-malate as substrate.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QP51AA10
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
CFR |
21 CFR 530.41
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
14885-29-1
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
DTXSID7046839
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
2660
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
C76423
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL334786
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
100000083145
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
m6393
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | Merck Index | ||
|
26951
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
045BU63E23
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
238-957-3
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
Ipronidazole
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
SUB08284MIG
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY | |||
|
109212
Created by
admin on Fri Dec 15 15:24:39 GMT 2023 , Edited by admin on Fri Dec 15 15:24:39 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)